Strategic Biopharma Consulting & Drug Development Leadership
Expertise in Oncology | Immunology | CMC & Formulation Development | Regulatory Strategy | Portfolio & Program Management
Drug Development & Portfolio Strategy - We provide strategic oversight for biotech and pharma companies focused on developing oncology, immunology, and advanced biologic therapies. From early-stage R&D to clinical execution, we ensure a science-driven, commercially viable approach to drug development.
Services
Helping biotech and pharma companies accelerate drug development, optimize drug development strategy, and de-risk product portfolios from early-stage research to commercialization.
Enterprise Drug Development, Pipeline
& Portfolio Strategy Optimization
Regulatory & Clinical
Strategy Enablement
CMC Tech Ops &
Manufacturing Strategy
Oncology & Immunoncology
Innovation
Business Market &
BD Strategy Support
Industry Expertise in oncology, immunology, and biologics development.
CMC & Formulation with hands-on experience in manufacturing strategy and CDMO selection.
Regulatory & Scientific Leadership for IND/BLA filings, FDA interactions, and portfolio strategy.
End-to-End Drug Development Insights from early research to commercialization.
Data-Driven Decision Making for pipeline evaluation, risk assessment, and competitive intelligence.
Tailored Consulting for Biotech Startups, Pharma, and Investors to optimize R&D, clinical, and regulatory strategy.
Speaking Engagements & Advisory Roles: Available for panels, keynotes, and biotech strategy sessions
Working Model
We are flexible with workload and understand that in a biotech/startup setting, some weeks may be lighter than others. We are open to adjusting hours based on project needs, ensuring that critical deliverables stay on track. Happy to discuss a setup that aligns with the company’s needs while maintaining efficiency.
Our Expertise & Services
Drug Development & Portfolio Strategy
We provide strategic oversight for biotech and pharma companies focused on developing oncology, immunology, and advanced biologic therapies. From early-stage R&D to clinical execution, we ensure a science-driven, commercially viable approach to drug development and help companies integrate data-driven approaches for asset evaluation and risk mitigation.
Key Services >>
Regulatory & Clinical Strategy Enablement
Navigating the complex global regulatory landscape is critical for timely approvals and competitive positioning. We help companies craft regulatory roadmaps that reduce delays and increase approval success rates.
Key Services >>
CMC Tech Ops & Manufacturing Strategy
We bridge the gap between science and manufacturability, ensuring a robust CMC strategy that accelerates clinical readiness and commercial success.
Key Services >>
Oncology & Immuno-oncology Innovation
With deep experience in oncology and immunotherapy, We provide insights into emerging therapeutic modalities and clinical differentiation strategies.
Key Services >>
Business, Market & BD Strategy
Beyond science and regulations, I help biotech startups, investors, and pharma companies craft market-driven strategies for growth and funding.
Key Services >>